• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

接受长期胺碘酮治疗的持续性室性心动过速或心室颤动患者猝死风险的分层

Stratification of sudden death risk in patients receiving long-term amiodarone treatment for sustained ventricular tachycardia or ventricular fibrillation.

作者信息

Olson P J, Woelfel A, Simpson R J, Foster J R

机构信息

Division of Cardiology, University of North Carolina School of Medicine, Chapel Hill.

出版信息

Am J Cardiol. 1993 Apr 1;71(10):823-6. doi: 10.1016/0002-9149(93)90831-v.

DOI:10.1016/0002-9149(93)90831-v
PMID:8456761
Abstract

One hundred twenty-two patients treated chronically with amiodarone for sustained ventricular tachycardia or ventricular fibrillation after failing conventional antiarrhythmic therapy were analyzed to determine which factors were predictive of sudden cardiac death during follow-up. The mean left ventricular ejection fraction in the study group was 0.32, and 87% of the patients had coronary artery disease with a prior myocardial infarction. During a median follow-up of 19.5 months, 30 patients died suddenly. The only variable that was predictive of sudden death was left ventricular ejection fraction. Twenty-nine of the 84 patients with ejection fractions < 0.40 died suddenly, compared with 1 of 35 patients with ejection fractions > or = 0.40. The actuarial probability of sudden death at 5 years was 49% when the ejection fraction was < 0.40, and 5% when the ejection fraction was > or = 0.40 (p = 0.0004). These results indicate that patients treated with amiodarone for sustained ventricular tachycardia or ventricular fibrillation whose ejection fractions are > or = 0.40 are at low risk for sudden death. Patients with ejection fractions < 0.40 remain at high risk for sudden death, and should be considered for additional or alternative therapy.

摘要

对122例在常规抗心律失常治疗失败后长期使用胺碘酮治疗持续性室性心动过速或室颤的患者进行分析,以确定哪些因素可预测随访期间的心源性猝死。研究组的平均左心室射血分数为0.32,87%的患者患有冠状动脉疾病且既往有心肌梗死病史。在中位随访19.5个月期间,30例患者突然死亡。唯一可预测猝死的变量是左心室射血分数。射血分数<0.40的84例患者中有29例突然死亡,而射血分数≥0.40的35例患者中有1例突然死亡。射血分数<0.40时,5年猝死的精算概率为49%,而射血分数≥0.40时为5%(p = 0.0004)。这些结果表明,射血分数≥0.40的持续性室性心动过速或室颤患者接受胺碘酮治疗时猝死风险较低。射血分数<0.40的患者仍有较高的猝死风险,应考虑进行额外或替代治疗。

相似文献

1
Stratification of sudden death risk in patients receiving long-term amiodarone treatment for sustained ventricular tachycardia or ventricular fibrillation.接受长期胺碘酮治疗的持续性室性心动过速或心室颤动患者猝死风险的分层
Am J Cardiol. 1993 Apr 1;71(10):823-6. doi: 10.1016/0002-9149(93)90831-v.
2
Predictors of mortality in patients with sustained ventricular tachycardias or ventricular fibrillation and depressed left ventricular function: importance of beta-blockade.
Am Heart J. 1995 Aug;130(2):281-6. doi: 10.1016/0002-8703(95)90441-7.
3
New primary prevention trials of sudden cardiac death in patients with left ventricular dysfunction: SCD-HEFT and MADIT-II.针对左心室功能不全患者的心脏性猝死新的一级预防试验:SCD-HEFT和MADIT-II。
Am J Cardiol. 1999 Mar 11;83(5B):91D-97D. doi: 10.1016/s0002-9149(99)00040-5.
4
Risk stratification and prognosis of patients treated with amiodarone for malignant ventricular tachyarrhythmias after myocardial infarction.心肌梗死后胺碘酮治疗恶性室性快速心律失常患者的危险分层与预后
Cardiovasc Drugs Ther. 1993 Aug;7(4):683-9. doi: 10.1007/BF00877822.
5
Antiarrhythmic drug therapy for sustained ventricular arrhythmias complicating acute myocardial infarction.抗心律失常药物治疗急性心肌梗死后持续性室性心律失常。
Crit Care Med. 2011 Jan;39(1):78-83. doi: 10.1097/CCM.0b013e3181fd6ad7.
6
Induction of ventricular fibrillation predicts sudden death in patients treated with amiodarone because of ventricular tachyarrhythmias after a myocardial infarction.对于心肌梗死后因室性快速心律失常而接受胺碘酮治疗的患者,诱发室颤预示着猝死。
Heart. 1996 Jan;75(1):23-8. doi: 10.1136/hrt.75.1.23.
7
[Risk stratification and long-term therapy with amiodarone in patients with idiopathic dilated cardiomyopathy].[特发性扩张型心肌病患者的风险分层及胺碘酮长期治疗]
Z Kardiol. 1992 Dec;81(12):704-9.
8
[Prognostic factors after sustained ventricular fibrillation or tachycardia. A multivariate study apropos of 160 cases].[持续性室颤或室速后的预后因素。一项针对160例病例的多变量研究]
Arch Mal Coeur Vaiss. 1996 Apr;89(4):435-44.
9
Effect of amiodarone therapy on mortality in patients with left ventricular dysfunction and asymptomatic complex ventricular arrhythmias: Argentine Pilot Study of Sudden Death and Amiodarone (EPAMSA).
Am Heart J. 1995 Sep;130(3 Pt 1):494-500. doi: 10.1016/0002-8703(95)90357-7.
10
Long-term results of amiodarone therapy in patients with recurrent sustained ventricular tachycardia or ventricular fibrillation.
J Am Coll Cardiol. 1989 Feb;13(2):442-9. doi: 10.1016/0735-1097(89)90525-1.

引用本文的文献

1
[ICD therapy as secondary prevention].[植入式心律转复除颤器治疗作为二级预防]
Herzschrittmacherther Elektrophysiol. 2010 Jun;21(2):96-101. doi: 10.1007/s00399-010-0075-0.
2
[Guidelines for the implantation of defibrillators].[除颤器植入指南]
Clin Res Cardiol. 2006 Dec;95(12):696-708. doi: 10.1007/s00392-006-0475-7.
3
Amiodarone: maximising survival benefit with empiric or guided therapy.
J Interv Card Electrophysiol. 2000 Jan;4 Suppl 1:51-5. doi: 10.1023/a:1009818229508.